Supernus Pharmaceuticals Inc (SUPN)
28.90
-0.26
(-0.89%)
USD |
NASDAQ |
May 20, 11:16
Supernus Pharmaceuticals Gross Profit (TTM): 520.77M for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 520.77M |
December 31, 2023 | 523.74M |
September 30, 2023 | 523.43M |
June 30, 2023 | 540.62M |
March 31, 2023 | 575.75M |
December 31, 2022 | 580.02M |
September 30, 2022 | 577.70M |
June 30, 2022 | 556.60M |
March 31, 2022 | 523.31M |
December 31, 2021 | 504.71M |
September 30, 2021 | 487.68M |
June 30, 2021 | 491.05M |
March 31, 2021 | 493.09M |
December 31, 2020 | 467.94M |
September 30, 2020 | 439.25M |
June 30, 2020 | 402.82M |
March 31, 2020 | 385.13M |
December 31, 2019 | 376.10M |
September 30, 2019 | 391.51M |
June 30, 2019 | 392.98M |
March 31, 2019 | 388.18M |
Date | Value |
---|---|
December 31, 2018 | 393.54M |
September 30, 2018 | 366.08M |
June 30, 2018 | 343.43M |
March 31, 2018 | 319.55M |
December 31, 2017 | 287.02M |
September 30, 2017 | 261.34M |
June 30, 2017 | 238.58M |
March 31, 2017 | 215.49M |
December 31, 2016 | 203.02M |
September 30, 2016 | 185.31M |
June 30, 2016 | 169.04M |
March 31, 2016 | 154.08M |
December 31, 2015 | 139.04M |
September 30, 2015 | 127.10M |
June 30, 2015 | 111.36M |
March 31, 2015 | 105.45M |
December 31, 2014 | 86.92M |
September 30, 2014 | 67.24M |
June 30, 2014 | 47.09M |
March 31, 2014 | 19.36M |
December 31, 2013 | 10.92M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
376.10M
Minimum
Dec 2019
580.02M
Maximum
Dec 2022
487.71M
Average
498.90M
Median
Gross Profit (TTM) Benchmarks
Dynavax Technologies Corp | 189.73M |
Pacira BioSciences Inc | 498.69M |
Esperion Therapeutics Inc | 188.05M |
Collegium Pharmaceutical Inc | 340.22M |
PetIQ Inc | 265.02M |